Prevalence of preclinical Alzheimer disease: Comparison of current classification systems
Objective To determine the prevalence of preclinical Alzheimer disease (AD) according to
current classification systems by examining CSF from a representative general population …
current classification systems by examining CSF from a representative general population …
Alzheimer disease as a clinical-biological construct—an International Working Group recommendation
Importance Since 2018, a movement has emerged to define Alzheimer disease (AD) as a
purely biological entity based on biomarker findings. The recent revision of the Alzheimer's …
purely biological entity based on biomarker findings. The recent revision of the Alzheimer's …
Preclinical Alzheimer's disease and its outcome: a longitudinal cohort study
Background New research criteria for preclinical Alzheimer's disease have been proposed,
which include stages for cognitively normal individuals with abnormal amyloid markers …
which include stages for cognitively normal individuals with abnormal amyloid markers …
Alzheimer's disease: What is it, how many people have it, and why do we need to know?
MS Albert, DA Drachman - Neurology, 2000 - AAN Enterprises
In 1907, when Alois Alzheimer first described the clinical and pathologic findings in the case
of 54-year-old Auguste D., her severe and progressive dementia had been grossly obvious …
of 54-year-old Auguste D., her severe and progressive dementia had been grossly obvious …
Preclinical Alzheimer disease: neuropsychological test performance 1.5 to 8 years prior to onset
J Saxton, OL Lopez, G Ratcliff, C Dulberg, LP Fried… - Neurology, 2004 - AAN Enterprises
Objective: To determine if individuals ultimately diagnosed with Alzheimer disease (AD)
exhibited evidence of cognitive impairment on neuropsychological tests administered …
exhibited evidence of cognitive impairment on neuropsychological tests administered …
A brief history of “Alzheimer disease” Multiple meanings separated by a common name
DS Knopman, RC Petersen, CR Jack Jr - Neurology, 2019 - AAN Enterprises
The field of Alzheimer disease (AD) has a nosologic problem: The diagnostic label
“Alzheimer disease” has several distinctive meanings. The term probable AD was …
“Alzheimer disease” has several distinctive meanings. The term probable AD was …
Research evaluation and diagnosis of probable Alzheimer's disease over the last two decades: I
Objective: To describe the experience of a research clinic diagnosing AD during the last two
decades, with special emphasis on patients who meet the National Institute of Neurological …
decades, with special emphasis on patients who meet the National Institute of Neurological …
Fitting the epidemiology and neuropathology of the early stages of Alzheimer's disease to prevent dementia
J Mar, M Soto-Gordoa, A Arrospide… - Alzheimer's research & …, 2015 - Springer
Introduction Recent research on biomarkers has made possible the diagnosis of pre-
dementia and even preclinical Alzheimer's disease (AD), thus providing the ideal context for …
dementia and even preclinical Alzheimer's disease (AD), thus providing the ideal context for …
Epidemiology of Alzheimer disease
The global prevalence of dementia is estimated to be as high as 24 million, and is predicted
to double every 20 years through to 2040, leading to a costly burden of disease. Alzheimer …
to double every 20 years through to 2040, leading to a costly burden of disease. Alzheimer …
Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease
DS Knopman, CR Jack Jr, HJ Wiste, SD Weigand… - Neurology, 2012 - AAN Enterprises
Objective: Recommendations for the diagnosis of preclinical Alzheimer disease (AD) have
been formulated by a workgroup of the National Institute on Aging and Alzheimer's …
been formulated by a workgroup of the National Institute on Aging and Alzheimer's …